PlainPharmaWatch

CMS Open Payments · Program Year 2024

Dompe Farmaceutici S.p.A.

Dompe Farmaceutici S.p.A. reported $6,935,889.54 in payments to 7 physicians and teaching hospitals across 2,668 transactions.

See the rankings → How this is sourced
$6.9M
Total payments
2,668
Transactions
7
Recipients
#222
of 1,925 companies

Dompe Farmaceutici S.p.A. reported $6,935,889.54 in payments to 7 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #222 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $990.8K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Dompe Farmaceutici S.p.A. pairs top-quartile payment volume with a moderately concentrated payment pattern.

#222
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
1
payment categories

How Dompe Farmaceutici S.p.A. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Dompe Farmaceutici S.p.A.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$6,935,890 Top 11% higher than 89% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Dompe Farmaceutici S.p.A.

$6,935,889.54: that is what Dompe Farmaceutici S.p.A. reported in payments to 7 physicians and teaching hospitals during Program Year 2024, spread across 2,668 transactions ($2.6K per transaction, $990.8K per recipient). The company sits at rank #222 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 1-category general-payment breakdown below at $11.8K (0.2% of the company's reported total, 7 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 1 types of general payments, Dompe Farmaceutici S.p.A.'s largest category was "Consulting Fee" at $11.8K - 0.2% of the company's reported total.

How Dompe Farmaceutici S.p.A. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$11.8K
Payment Type Amount Transactions
Consulting Fee $11.8K 7

Recipient Concentration in General Payments

The five largest recipient relationships account for $10,462.50 (88.4%) of $11,837.50 in this company's General Payments records across 7 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Dompe Farmaceutici S.p.A.

The five named recipients with the highest reported General Payments from this company

Alena Reznik$2.4KGeorge a Cioffi$2.3KRoma Patel$2.3KAhmara G Ross$2.3KDavid Hardten$1.3K
  1. 1

    Alena Reznik

    $2,400.00 across 1 reported transactions

  2. 2

    George a Cioffi

    $2,250.00 across 1 reported transactions

  3. 3

    Roma Patel

    $2,250.00 across 1 reported transactions

  4. 4

    Ahmara G Ross

    $2,250.00 across 1 reported transactions

  5. 5

    David Hardten

    $1,312.50 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $2.6K. Average per recipient: $990.8K.

Total Amount

$6,935,889.54

Avg per Transaction

$2.6K

Avg per Recipient

$990.8K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Dompe Farmaceutici S.p.A. Share

0.0%

#222 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Dompe Farmaceutici S.p.A.

Astellas Pharma Inc

$6.9M 81 recipients

Woven Orthopedic Technologies, LLC

$7.0M 11 recipients

Astellas US Technologies

$6.9M 0 recipients

Neurology Practice Consortium Gpo, LLC

$7.0M 0 recipients

Johnson & Johnson Vision Care, Inc.

$6.8M 29,358 recipients

Aptis Medical, LLC

$6.8M 95 recipients

Frequently Asked Questions

How much did Dompe Farmaceutici S.p.A. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Dompe Farmaceutici S.p.A., totaling $6,935,889.54 across 2,668 transactions to physicians and hospitals.
How many physicians received payments from Dompe Farmaceutici S.p.A.? ▾
Averaging $990.8K per recipient, Dompe Farmaceutici S.p.A.'s 2024 payments reached 7 physicians and teaching hospitals.
What types of payments did Dompe Farmaceutici S.p.A. make? ▾
1 categories of general payment make up Dompe Farmaceutici S.p.A.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $11.8K, representing 0.2% of the company's reported total.
How does Dompe Farmaceutici S.p.A. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Dompe Farmaceutici S.p.A. ranks #222 by total payment amount.
What is the average payment size from Dompe Farmaceutici S.p.A.? ▾
In 2024, Dompe Farmaceutici S.p.A. averaged $2.6K per transaction across 2,668 transactions to 7 recipients.
Where does the payment data for Dompe Farmaceutici S.p.A. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Dompe Farmaceutici S.p.A.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.